Exogenous interferon prolongs survival of rabies infected mice
- PMID: 26396983
- PMCID: PMC4571584
- DOI: 10.1007/s13337-015-0269-5
Exogenous interferon prolongs survival of rabies infected mice
Abstract
Rabies is an acute viral infection that causes encephalomyelitis in almost all warm blooded animals and is invariably fatal once the clinical signs appear. The present study was carried out to assess the effect of recombinant human interferon alpha (rhIFN α-2A) treatment on the survival of rabies infected mice and its correlation with cytokines expression. The gene expression of TNF-α and IL-6 was measured by SYBR Green Real Time PCR for two groups-"Pre-exposure" (mice were inoculated with rhIFN α-2A prior to rabies infection) and "Post-exposure" (mice were inoculated with rhIFN α-2A post rabies virus infection). Delayed mortality was observed in interferon treated infected groups. In addition, statistically significant decrease (P < 0.0001) in the expression of TNF-α and IL-6 was observed, both in the pre-exposure and post-exposure groups. These findings indicate that modulation of cytokine secretion using exogenous biologicals such as rhIFN may offer novel therapeutic approaches to treat diseases such as rabies.
Keywords: Cytokines; Interferon; Rabies; Therapeutic.
Figures



Similar articles
-
Evaluation of neuroimmunomodulatory activity of recombinant human interferon α.Neuroimmunomodulation. 2014;21(5):250-6. doi: 10.1159/000357309. Epub 2014 Mar 1. Neuroimmunomodulation. 2014. PMID: 24603728
-
The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model.Vaccine. 2019 Aug 2;37(33):4715-4723. doi: 10.1016/j.vaccine.2017.10.098. Epub 2017 Nov 15. Vaccine. 2019. PMID: 29153584
-
A preliminary study of recombinant human interferon-α-2a activity against rabies virus in murine model.Indian J Med Microbiol. 2015 Jan-Mar;33(1):132-5. doi: 10.4103/0255-0857.148412. Indian J Med Microbiol. 2015. PMID: 25560017
-
Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery.Infect Disord Drug Targets. 2011 Jun;11(3):251-99. doi: 10.2174/187152611795768079. Infect Disord Drug Targets. 2011. PMID: 21488832 Review.
-
Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review.Vet Q. 2017 Dec;37(1):212-251. doi: 10.1080/01652176.2017.1343516. Vet Q. 2017. PMID: 28643547 Review.
Cited by
-
Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms.Int J Vet Sci Med. 2018 May 18;6(1):8-15. doi: 10.1016/j.ijvsm.2018.05.001. eCollection 2018 Jun. Int J Vet Sci Med. 2018. PMID: 30255072 Free PMC article. Review.
References
-
- Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol. 1999;163(7):3963–3968. - PubMed
-
- (CDC) CfDCaP. Protocol for postmortem diagnosis of rabies in animals by direct fluorescent antibody testing. A minimum standard for rabies diagnosis in the United States. Atlanta.
LinkOut - more resources
Full Text Sources
Other Literature Sources